Effect Of Ph And Imidazole On Protein C Purification From Cohn Fraction Iv-1 By Imac

  • James J. Lee
  • Duane F. Bruley
  • Kyung A. Kang
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 599)


Cohn Fraction IV-1 (CFIV-1) is a by-product (often discarded) of a plasma fractionation process. It retains 90% of Protein C (PC) of plasma but contains several coagulants structurally homologous to PC. Of these coagulants, Factor II (FII) has the longest half-life (12 times of PC) and largest quantity (9 times of PC) in CFIV-1. Current purification process for PC is by immunoaffinity chromatography using monoclonal antibodies, which is very expensive. Immobilized metal affinity chromatography (IMAC) is an inexpensive process that uses metal ions to adsorb proteins via their surface histidines. Affinity of PC to the metal ions in IMAC is higher than that of FII because PC has 15 surface histidines and FII has 5. Two important factors in an IMAC process are pH and imidazole concentration. PH controls protonation of histidine, and imidazole, a histidine analog, competitively reacts with metal ions. The effects of pH and imidazole on adsorption and elution of PC and FII during IMAC process were studied. The effect of pH on PC and FII adsorption was similar within the range of 6.0 and 8.0. At concentrations below 15 mM imidazole, little PC or FII eluted. At 15 and 20 mM imidazole 2.5% of PC was eluted, while 20-30% of FII was eluted.


Histidine Residue Immobilize Metal Affinity Chromatography Iminodiacetic Acid Immunoaffinity Chromatography Cupric Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    C. T. Esmon, The Anticoagulant and Anti-Inflammatory Roles of the Protein C Anticoagulant Pathway, J. Autoimmun. 15, 113-116 (2000).PubMedCrossRefGoogle Scholar
  2. 2.
    C. T. Esmon, Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation, Crit. Care Med. 29(7) 48-51 (2001).CrossRefGoogle Scholar
  3. 3.
    D. E. Joyce, L. Gelbert, A. Ciaccia, B. DeHoff and B. W. Grinnell, Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. Journal of Biol. Chem.,276 11199-11203 (2001).CrossRefGoogle Scholar
  4. 4.
    T. Cheng, D. Liu, J. H. Griffin, J. A Fernandez, F. Castellino, E. D. Rosen, K. Fukudome and B. V. Zlokovic, Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and its neuroprotective, Nat. Med., 9 (3) 338-342 (2003).PubMedCrossRefGoogle Scholar
  5. 5.
    D. Liu, T. Cheng, H. Guo, J. A. Fernandez, J. H. Griffin, X. Song and B. V. Zlokovic, Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C, Nat. Med., 10 (12) 1379-1383 (2004).PubMedCrossRefGoogle Scholar
  6. 6.
    R. M. Bertina, Protein C and Related Proteins; Biochemical and Clinical Aspects, (Churchill Livingstone, New York, 1998), pp. 1-54.Google Scholar
  7. 7.
    D. F. Bruley and W. N. Drohan, Advances in Applied Biotechnology Series; Protein C and Related Anticoagulants, 11 (Gulf Publications, Houston, TX 1990).Google Scholar
  8. 8.
    S. Rezania, D. G. Ahn and K. A. Kang, Separation of Protein C from Cohn Fraction IV-1 by Mini-Antibody, Proceedings of the 33 Annual ISOTT meeting 2005 [In Review].Google Scholar
  9. 9.
    L. H. Edmunds and E. W. Salzman, Hemostatic Problems, Transfusion Therapy, and Cardiopulmonary Bypass in Surgical Patients, Hemostasis and Thrombosis, 3rd Ed., edited by R. W. Colman, J. Hirsh, V. J. Marder and E. W. Salzman, (J. B. Lippincott Co, Philadelphia, 1994), p. 958.Google Scholar
  10. 10.
    G. J. Broze Jr. and J. P. Miletich, Biochemistry and Physiology of Protein C, Protein S, and Thrombomodulin, Hemostasis and Thrombosis, edited by ,R. W. Colman, J. Hirsh, V. J. Marder and E. W. Salzman, (J. B. Lippincott Co., Philadelphia, 1994), p. 262.Google Scholar
  11. 11.
    A. S. Wolberg, D. M. Monroe, H. R. Roberts and M. Hoffman, Elevated prothrombin results in clots with and altered fiber structure: a possible mechanism of the increased thrombotic risk, Blood, 101, 3008-3013 (2003).PubMedCrossRefGoogle Scholar
  12. 12.
    H. Wu and D. F. Bruley, Homologous human blood protein separation using immobilized metal affinity chromatography: protein C separation from prothrombin with application to the separation of factor IX and prothrombin, Biotechnol. Progr. 15, 928 (1999).CrossRefGoogle Scholar
  13. 13.
    H. Wu, and D. F. Bruley, Chelator, metal ion and buffer studies for protein C separation, Comp. Biochem. Physiol. Part A 132, 213-220 (2002).CrossRefGoogle Scholar
  14. 14.
    H. Wu, D. F. Bruley, K. A. Kang, Protein C Separation form human plasma Cohn fraction IV-1 using immobilized metal affinity chromatography, Adv. Exp. Med. & Bio.: Oxy. Trans. to Tis. XX, 454, (Plenum Press, New York, 1998), pp. 697-704.Google Scholar
  15. 15.
    M. Zachariou and M. T. W. Hearn, Characterization by Potentiometric Procedures of the Acid-Base and Metal Binding Properties of two New Classes of Immobilized Metal Ion Affinity Adsorbents Developed for Protein Purification, Journal of Analytical Chemistry, 69, 813-822 (1997).CrossRefGoogle Scholar
  16. 16.
    E. S. Hemdan, Y. J. Zhao, E. Sulkowski and J. Porath, Surface topography of hisitdine residues: A facile probe by immobilized metal ion affinity chromatography, Proceedings of the National Academy of Science USA, 86 (1989) 1811-1815.CrossRefGoogle Scholar
  17. 17.
    J. J. Lee, E. E. Thiessen and D. F. Bruley, Protein C Production; Metal Ion/Protein Interfacial Interaction in Immobilized Metal Affinity Chromatography, Adv. Exp. Med. & Bio.: Oxy. Trans. to Tis. XXVI, 566, (Springer-Verlag, New York, 2005).Google Scholar
  18. 18.
    E. E. Thiessen, and D. F. Bruley, Theoretical Studies of IMAC Interfacial Phenomena for the Purification of Protein C, Adv. Exp. Med. & Bio.: Oxy. Trans. to Tis. XXV, 540, (Kluwer Academic/Plenum Press, New York, 2003), pp 183-190.Google Scholar
  19. 19.
    E. K .M. Ueda, P. W. Goutt and L. Moranti., Rev. of “Current and prospective application of metal ion-protein binding,” J. of Chromatography A 988, 1-23 (2003).CrossRefGoogle Scholar
  20. 20.
    R. Nandakumar, H. Afshari and D. F. Bruley, Analysis of Equilibrium Adsorption Isotherms for Human Protei C Purification by Immobilized Metal Affinity Chromatography, Adv. Exp. Med. & Bio.: Oxy. Trans. to Tis. XXV, 540, (Kluwer Academic/Plenum Press, New York, 2003), pp. 191-199.Google Scholar
  21. 21.
    T. W. Hutchens, T. T. Yip and J. Porath, Protein Interaction with Immobilized Ligands: Quantitative Analyses of Equilibrium Partition Data and Comparison with Analytical Chromatographic Approaches Using Immobilized Metal Affinity Chromatography, Analytical Biochemistry 170, 168-182 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • James J. Lee
    • 1
  • Duane F. Bruley
    • 2
  • Kyung A. Kang
    • 1
  1. 1.Department of Chemical EngineeringUniversity of LouisvilleLouisvilleUSA
  2. 2.Department of Chemical and Biochemical EngineeringUniversity of Maryland Baltimore CountyBaltimoreUSA

Personalised recommendations